[Articles] Blinded outcomes and angina assessment of coronary bioresorbable scaffolds: 30-day and 1-year results from the ABSORB IV randomised trial
November 5, 2018
- The Lancet 392, 10157 (2018)
Author: Gregg W Stone, Stephen G Ellis, Tommaso Gori, D Christopher Metzger, Bernardo Stein, Matthew Erickson, Jan Torzewski, Jerome Williams, William Lawson, Thomas M Broderick, Ameer Kabour, Guy Piegari, Jeffrey Cavendish, Barry Bertolet, James W Choi, Steven O Marx, Philippe Généreux, Dean J Kereiakes, ABSORB IV Investigators
Polymeric BVS implanted with optimised technique in an expanded patient population resulted in non-inferior 30-day and 1-year rates of target lesion failure and angina compared with metallic DES.